Treace Medical Concepts (TMCI) News Today $7.98 +0.22 (+2.84%) (As of 11/20/2024 ET) Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street TipRanks The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 December 2021 Time Period Treace Announces Participation at Stifel 2024 Healthcare ConferenceNovember 18 at 4:46 PM | globenewswire.comTMCI Investors Have Opportunity to Join Treace Medical Concepts, Inc. Fraud Investigation with the Schall Law FirmNovember 12, 2024 | prnewswire.comAnalysts Offer Insights on Healthcare Companies: Treace Medical Concepts (TMCI), MacroGenics (MGNX) and Novo Nordisk (NVO)November 7, 2024 | markets.businessinsider.comMorgan Stanley Sticks to Its Hold Rating for Treace Medical Concepts (TMCI)November 7, 2024 | markets.businessinsider.comTreace Medical Concepts, Inc. (NASDAQ:TMCI) Q3 2024 Earnings Call TranscriptNovember 7, 2024 | insidermonkey.comTreace Medical Concepts Inc (TMCI) Q3 2024 Earnings Call Highlights: Strong Revenue Growth and ...November 6, 2024 | finance.yahoo.comTreace Medical Concepts Reports Strong Q3 2024 GrowthNovember 6, 2024 | markets.businessinsider.comTreace Medical Concepts, Inc. (TMCI) Q3 2024 Earnings Call TranscriptNovember 5, 2024 | seekingalpha.comTREACE ALERT: Bragar Eagel & Squire, P.C. is Investigating Treace Medical Concepts, Inc. on Behalf of Treace Stockholders and Encourages Investors to Contact the FirmNovember 5, 2024 | globenewswire.comTreace Medical Concepts Reports Third Quarter 2024 Financial ResultsNovember 5, 2024 | globenewswire.comTreace Medical comments on CMS final rule for hospital outpatient, ASC settingsNovember 5, 2024 | markets.businessinsider.comTreace Medical announces limited release of Nanoplasty 3D MIS Bunion CorrectionNovember 5, 2024 | markets.businessinsider.comTreace Enters High Volume Osteotomy Market with Nanoplasty™ 3D Minimally Invasive Bunion Correction™ ProcedureNovember 5, 2024 | markets.businessinsider.comEarnings Preview For Treace Medical ConceptsNovember 5, 2024 | benzinga.comTreace Announces Participation in the UBS Global Healthcare ConferenceNovember 4, 2024 | globenewswire.comTMCI Investors Have Opportunity to Join Treace Medical Concepts, Inc. Fraud Investigation with the Schall Law FirmNovember 4, 2024 | prnewswire.comGlancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of Treace Medical Concepts, Inc. (TMCI) on Behalf of InvestorsNovember 1, 2024 | businesswire.comINVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation of Treace Medical Concepts, Inc. (TMCI) on Behalf of InvestorsNovember 1, 2024 | tmcnet.comThe Law Offices of Frank R. Cruz Announces Investigation of Treace Medical Concepts, Inc. (TMCI) on Behalf of InvestorsOctober 31, 2024 | businesswire.comTreace Medical participates in a conference call with BTIGOctober 31, 2024 | markets.businessinsider.comTreace Medical Concepts, Inc. (NASDAQ:TMCI) Given Consensus Recommendation of "Hold" by AnalystsShares of Treace Medical Concepts, Inc. (NASDAQ:TMCI - Get Free Report) have been given a consensus recommendation of "Hold" by the six analysts that are presently covering the firm, Marketbeat.com reports. Six equities research analysts have rated the stock with a hold rating. The average 1-yearOctober 30, 2024 | marketbeat.comTreace Medical Concepts (TMCI) Scheduled to Post Quarterly Earnings on TuesdayTreace Medical Concepts (NASDAQ:TMCI) will be releasing earnings after the market closes on Tuesday, November 5, Zacks reports. (Register for Conference Call at http://mmm.wallstreethorizon.com/u.asp?u=435653)October 29, 2024 | marketbeat.comTREACE ALERT: Bragar Eagel & Squire, P.C. is Investigating Treace Medical Concepts, Inc. on Behalf of Treace Stockholders and Encourages Investors to Contact the FirmOctober 28, 2024 | globenewswire.comTMCI Investors Have Opportunity to Join Treace Medical Concepts, Inc. Fraud Investigation with the Schall Law FirmOctober 28, 2024 | prnewswire.comTMCI Investors Have Opportunity to Join Treace Medical Concepts, Inc. Fraud Investigation with the Schall Law FirmOctober 23, 2024 | prnewswire.comTreace to Report Third Quarter 2024 Financial Results on November 5, 2024October 22, 2024 | globenewswire.comTMCI Investors Have Opportunity to Join Treace Medical Concepts, Inc. Fraud Investigation with the Schall Law FirmOctober 22, 2024 | businesswire.comTreace Medical Concepts (NASDAQ:TMCI) PT Lowered to $6.00 at Truist FinancialTruist Financial reduced their price target on shares of Treace Medical Concepts from $7.50 to $6.00 and set a "hold" rating on the stock in a research report on Monday.October 14, 2024 | marketbeat.comTreace Files Patent Infringement and Unfair Competition Suit to Protect Lapiplasty® Bunion TechnologyOctober 14, 2024 | globenewswire.comMillennium Management LLC Trims Stake in Treace Medical Concepts, Inc. (NASDAQ:TMCI)Millennium Management LLC cut its holdings in Treace Medical Concepts, Inc. (NASDAQ:TMCI - Free Report) by 66.4% in the second quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 686,012 shares of the company's stockOctober 13, 2024 | marketbeat.comTreace Medical Concepts Inc (TMCI) Q2 2024 Earnings Call Highlights: Navigating Growth Amidst ...October 9, 2024 | finance.yahoo.comAlgert Global LLC Buys 104,236 Shares of Treace Medical Concepts, Inc. (NASDAQ:TMCI)Algert Global LLC raised its stake in Treace Medical Concepts, Inc. (NASDAQ:TMCI - Free Report) by 178.8% during the second quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 162,536 shares of the company's stock after acquiring an addOctober 5, 2024 | marketbeat.comTreace Medical Concepts, Inc. (NASDAQ:TMCI) Given Consensus Rating of "Hold" by AnalystsTreace Medical Concepts, Inc. (NASDAQ:TMCI - Get Free Report) has earned an average rating of "Hold" from the six analysts that are presently covering the company, Marketbeat Ratings reports. Six equities research analysts have rated the stock with a hold recommendation. The average 12-month priceOctober 5, 2024 | marketbeat.comMarshall Wace LLP Boosts Holdings in Treace Medical Concepts, Inc. (NASDAQ:TMCI)Marshall Wace LLP boosted its position in Treace Medical Concepts, Inc. (NASDAQ:TMCI - Free Report) by 65.9% during the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 463,039 shares of the company's stock afteOctober 4, 2024 | marketbeat.comPoint72 Asset Management L.P. Acquires Shares of 362,710 Treace Medical Concepts, Inc. (NASDAQ:TMCI)Point72 Asset Management L.P. acquired a new stake in shares of Treace Medical Concepts, Inc. (NASDAQ:TMCI - Free Report) in the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm acquired 362,710 shares of the companOctober 3, 2024 | marketbeat.comLighthouse Investment Partners LLC Buys New Holdings in Treace Medical Concepts, Inc. (NASDAQ:TMCI)Lighthouse Investment Partners LLC purchased a new position in shares of Treace Medical Concepts, Inc. (NASDAQ:TMCI - Free Report) during the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund purchased 167,500 shaSeptember 29, 2024 | marketbeat.comArmistice Capital LLC Increases Holdings in Treace Medical Concepts, Inc. (NASDAQ:TMCI)Armistice Capital LLC raised its stake in Treace Medical Concepts, Inc. (NASDAQ:TMCI - Free Report) by 123.3% in the 2nd quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 5,360,000 shares of the company's stoSeptember 26, 2024 | marketbeat.comTreace Medical Concepts (TMCI) Slid on Reduced GuidanceSeptember 18, 2024 | finance.yahoo.comC$ dips as inflation data fuels BoC upsized rate cut talkSeptember 18, 2024 | ca.finance.yahoo.comTreace Medical Concepts, Inc. (NASDAQ:TMCI) CEO Buys 50,000 SharesSeptember 18, 2024 | insidertrades.comJohn T. Treace Acquires 50,000 Shares of Treace Medical Concepts, Inc. (NASDAQ:TMCI) StockTreace Medical Concepts, Inc. (NASDAQ:TMCI - Get Free Report) CEO John T. Treace purchased 50,000 shares of the company's stock in a transaction on Monday, September 16th. The shares were bought at an average cost of $5.31 per share, with a total value of $265,500.00. Following the transaction, the chief executive officer now directly owns 6,523,095 shares of the company's stock, valued at approximately $34,637,634.45. The acquisition was disclosed in a filing with the SEC, which is accessible through this link.September 17, 2024 | marketbeat.comWilliam Blair Investment Management LLC Grows Stock Holdings in Treace Medical Concepts, Inc. (NASDAQ:TMCI)William Blair Investment Management LLC lifted its position in shares of Treace Medical Concepts, Inc. (NASDAQ:TMCI - Free Report) by 58.0% during the second quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 3,681,718 shares of the company'sSeptember 16, 2024 | marketbeat.comAcadian Asset Management LLC Invests $2.25 Million in Treace Medical Concepts, Inc. (NASDAQ:TMCI)Acadian Asset Management LLC acquired a new stake in Treace Medical Concepts, Inc. (NASDAQ:TMCI - Free Report) in the 2nd quarter, according to the company in its most recent disclosure with the SEC. The fund acquired 338,219 shares of the company's stock, valued at approximately $2,247,000. AcadiaSeptember 14, 2024 | marketbeat.comTreace Highlights New Product Innovations and Updated Clinical Study Data at the American Orthopaedic Foot & Ankle Society Annual Meeting 2024September 11, 2024 | globenewswire.comTreace Medical Concepts, Inc. (NASDAQ:TMCI) Receives Consensus Recommendation of "Hold" from AnalystsShares of Treace Medical Concepts, Inc. (NASDAQ:TMCI - Get Free Report) have been given an average rating of "Hold" by the seven brokerages that are presently covering the company, Marketbeat reports. Seven research analysts have rated the stock with a hold recommendation. The average 1 year priceSeptember 10, 2024 | marketbeat.comMaintaining Hold on Treace Medical Concepts Amidst Stable Growth and Anticipated Product LaunchesSeptember 7, 2024 | markets.businessinsider.comKornitzer Capital Management Inc. KS Sells 150,815 Shares of Treace Medical Concepts, Inc. (NASDAQ:TMCI)Kornitzer Capital Management Inc. KS lessened its position in Treace Medical Concepts, Inc. (NASDAQ:TMCI - Free Report) by 22.3% in the second quarter, according to its most recent disclosure with the SEC. The firm owned 526,918 shares of the company's stock after selling 150,815 shares during theSeptember 6, 2024 | marketbeat.comTreace Announces Participation in the Morgan Stanley 22nd Annual Global Healthcare ConferenceAugust 22, 2024 | globenewswire.comJames T. Treace Buys 84,000 Shares of Treace Medical Concepts, Inc. (NASDAQ:TMCI) StockAugust 20, 2024 | insidertrades.comJames T. Treace Purchases 84,000 Shares of Treace Medical Concepts, Inc. (NASDAQ:TMCI) StockTreace Medical Concepts, Inc. (NASDAQ:TMCI - Get Free Report) Director James T. Treace bought 84,000 shares of the stock in a transaction that occurred on Thursday, August 15th. The stock was purchased at an average price of $5.96 per share, for a total transaction of $500,640.00. Following the completion of the purchase, the director now directly owns 1,223,441 shares in the company, valued at approximately $7,291,708.36. The transaction was disclosed in a filing with the SEC, which is available through this link.August 19, 2024 | marketbeat.com Get Treace Medical Concepts News Delivered to You Automatically Sign up to receive the latest news and ratings for TMCI and its competitors with MarketBeat's FREE daily newsletter. Email Address JD Vance Predicts: Wall Street vs. Trump & Your Money (Ad)Trump's back in the White House, but Wall Street is pissed. Here's the deal: Wall Street's about to purposely crash the bond market to sabotage Trump's comeback. Get your free guide NOW before it's too late. TMCI Media Mentions By Week TMCI Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. TMCI News Sentiment▼0.250.46▲Average Medical News Sentiment TMCI News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. TMCI Articles This Week▼13▲TMCI Articles Average Week Get Treace Medical Concepts News Delivered to You Automatically Sign up to receive the latest news and ratings for TMCI and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Organogenesis News AngioDynamics News Tandem Diabetes Care News RxSight News NovoCure News InMode News MiMedx Group News Artivion News Establishment Labs News Pulse Biosciences News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:TMCI) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | Sponsored24/7 Automated Profits in CryptoThe 4th quarter of 2024 is shaping up to be one of the most explosive periods for crypto in recent memory. But...Crypto Swap Profits | SponsoredTrump Wins… But Elon Says Get Ready to BraceTrump's back in the White House, ready to hit the gas on America's comeback. He's taking on the economy wi...Genesis Gold Group | SponsoredBut another coin could soar even higher …Donald Trump wants to be America’s first crypto president. He was the keynote speaker at the recent Bitcoin co...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Treace Medical Concepts, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Treace Medical Concepts With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free TMCI Stock Alerts